Danielle Daee, PhD
Program Director, Epidemiology and Genomics Research Program
danielle.daee@nih.gov
About CaPTC
Because the problem of prostate cancer disparity persists, it is crucial that we begin to use new paradigms and look at the problem from fresh perspectives to develop effective solutions. The possibility for exploring new paradigms comes from studying Blacks who are connected to the U.S. via the Transatlantic Slave Trade.
CaPTC Nigeria Workshop - March 9, 2017 - Abeokuta, Nigeria
The Prostate Cancer Transatlantic Consortium (CaPTC) was formed in 2005 to address the globally disproportionate burden of prostate cancer among Black men. CaPTC is an open consortium comprising a team of prostate cancer scientists, clinicians, survivors, and advocates from North America, Europe, the Caribbean Islands, and West Africa.
CaPTC's research goals are to:
- explore and quantify the magnitude of prostate cancer morbidity and mortality variance among Black men;
- explore the genetic and environmental etiology of this variance, using valid and reliable instruments and biomarkers; and
- develop ethnically sensitive, targeted approaches that will eliminate globally the prostate cancer disparities of Black men through modifiable risk factors associated with prostate cancer.
View CaPTC Research Publications
Administrative leadership of CaPTC comprises the Consortium Director, Scientific Advisory Board, and the Community Advisory Board.
Additionally, members of CaPTC have formed working groups focused on translational research, education and training, and advocacy.
Conferences
CaPTC organizes biennial conferences on "The Science of Global Prostate Cancer Disparities in Black Men." The first conference, held in 2010, was supported by NCI's Division of Cancer Control and Population Sciences (DCCPS) and the Division of Cancer Prevention (DCP).
The next conference will be divided into virtual and in-person sessions. There was a virtual conference in December 2020. In-person sessions will take place in Fall 2021, pending the ability for participants to travel safely and significantly reduced transmission of COVID-19.
CaPTC Conference Date | Location |
---|---|
December 6-10, 2020 | Virtual |
November 7-10, 2018 | Ilorin, Nigeria |
November 9-12, 2016 | Orlando, Florida, US |
November 5-8, 2014 | Montego Bay, Jamaica [PDF - 214 KB] |
November 1-4, 2012 | Nassau, The Bahamas [PDF] |
August 27-29, 2010 | Jacksonville, Florida, US |
Global Congress on Clinical Trials in Blacks
Although the Black population is about 17% of the world population (over one billion), Blacks are disproportionately affected by cancer globally. Given the disproportionate burden of cancer in Blacks, it is important to have a significant number of Blacks participate in cancer clinical trials globally. Unfortunately, the accrual of Blacks all over the world in clinical research remains low despite ongoing attempts to improve their participation. The under-representation of Blacks in clinical trials continues to magnify the cancer health disparities experienced by this group. Overcoming the barriers for successful clinical trial enrollment of Blacks continues to be a significant challenge.
The Global Congress on Oncology Clinical Trials for Blacks is an international conference organized to address the global challenges of clinical trials for oncology among the Black population. The conference was held from November 14 to 16, 2018, at the Intercontinental Hotel in Lagos, Nigeria. Nigeria was selected as the conference location because it has the largest Black population in the world.
Conference Sponsorship and Exhibition
Would your organization like to participate as sponsors and/or exhibitors at these conferences? Please contact us at flacaptc@mayo.edu.
Membership
Membership is open to anyone interested in eliminating the worldwide disproportionate burden of prostate cancer in black men can.
Join the CaPTCTransatlantic Prostate Cancer Familial Project
The long-term goal of this CaPTC research program is to eliminate the prostate cancer disparity experienced by Black men globally. In line with this goal, this project focuses on understanding the genetic, environmental and behavioral etiology of prostate cancer in West African men.
Participating CaPTC Familial Project Sites
U.S. Sites | Principal Investigators |
---|---|
Mayo Clinic Jacksonville | Dr. Folakemi Odedina |
Tuskegee University | Dr. Clayton Yates |
Sites in Nigeria – Region 1 | Principal Investigators |
---|---|
Covenant University | Dr. Emeka E.J. Iweala |
Lagos University Teaching Hospital | Dr. Anthonia Sowumni |
Lagos State University Teaching Hospital | Dr. Omolara Fatriegun |
Federal University of Agriculture Abeokuta | Dr. Catherine Adebukola Badejo |
Ace Medicare Clinics Limited, Ota | Dr. O.O. Kukoyi |
University of Calabar | Dr. Iya Eze Bassey |
Federal Medical Center, Abeokuta | Dr. Chidiebere Ndukwe Ogo |
Sites in Nigeria – Region 2 | Principal Investigators |
---|---|
Obafemi Awolowo University Teaching Hospitals | Prof. A.A. Salako |
Ahmadu Bello University | Dr. Mohammed Faruk |
University of Ilorin | Dr. Ademola Popoola |
Hebron Medical Center | Dr. Adebanji Adeniji |
University of Maiduguri | Prof. H. A. Nggada |
University of Abuja | Dr. Paul Jibrin |
University of Ibadan | Dr. Adenike Onibokun |
Federal Medical Centre Bida | Dr. Obafemi Aina |
University of Nigeria/University of Nigeria Teaching Hospital | Prof. Ifeoma Okoye |
Cameroon Site | Principal Investigator |
---|---|
University Hospital Center Yaounde | Dr. Blaise Nkegoum |
Sierra Leone Site | Principal Investigator |
---|---|
University of Sierra Leone | Prof. Babatunde Duduyem |
Cote d'lvoire Site | Principal Investigator |
---|---|
Pasteur Institute | Dr. Safiatou Coulibaly |